science top stories popular news  

Daily non-political popular news in brief.

Commonly Used Antidepressants May Prevent Bone Loss

10-13-2006 · ScienceDaily

Scientists at the Forsyth Institute have found that fluoxetine, a drug used in the treatment of depression and obsessive-compulsive disorders, increases bone mass. The team of researchers analyzed the ability of fluoxetine to stimulate new bone formation under normal conditions and to block bone loss caused by inflammation or estrogen loss due to ovariectomy. They found that the antidepressant induced the formation of new bone under normal conditions and reversed total bone loss triggered by inflammation.

Read more »

Keywords: commonly, used, antidepressants, prevent, bone, loss, antidepressant

« Previous | Next »

Similar news on "Commonly Used Antidepressants May Prevent Bone Loss":

  1. Commonly prescribed antidepressants associated with lower bone density in older men and women
    06-25-2007 · EurekAlert!
    The class of antidepressant medications known as selective serotonin reuptake inhibitors may be associated with an increased rate of bone loss in older men and women, according to two articles in the June 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
    Similar news · Read more »
  2. Forsyth scientists find linkages between serotonin reuptake inhibitors and bone mass
    10-13-2006 · EurekAlert!
    Scientists at the Forsyth Institute have found that fluoxetine, a drug used in the treatment of depression and obsessive-compulsive disorders, increases bone mass. The team of researchers analyzed the ability of fluoxetine to stimulate new bone formation under normal conditions and to block bone loss caused by inflammation or estrogen loss due to ovariectomy. They found that the antidepressant induced the formation of new bone under normal conditions and reversed total bone loss triggered by inflammation.
    Similar news · Read more »
  3. OHSU scientists find antidepressant, bone loss link
    06-25-2007 · EurekAlert!
    Two new studies suggest older men and women taking selective serotonin reuptake inhibitors, a class of antidepressants that includes Prozac, Paxil and Zoloft, are prone to increased bone loss. The jointly released studies by scientists at Oregon Health & Science University, and in San Francisco, Minneapolis, San Diego and Pittsburgh, found that elderly men taking SSRIs had lower bone mineral density, and elderly women taking the antidepressants had a higher rate of yearly bone loss.
    Similar news · Read more »
  4. Researchers urge monitoring of bone health during chemotherapy
    01-11-2007 · EurekAlert!
    In laboratory tests on mice, researchers found that a medication often used to reduce toxic side effects of chemotherapy induced bone loss and helped tumors grow in bone. So the researchers at Washington University School of Medicine in St. Louis are recommending increased awareness of bone health during cancer treatments.
    Similar news · Read more »
  5. Walking prevents bone loss caused from prostate cancer treatment
    10-28-2007 · EurekAlert!
    Exercise may reduce, and even reverse, bone loss caused by hormone and radiation therapies used in the treatment of localized prostate cancer, thereby decreasing the potential risk of bone fractures and improving quality of life for these men, according to a study presented on Oct. 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
    Similar news · Read more »
  6. Yerkes researchers pave the way for earlier diagnosis and treatment of retinal degenerative diseases
    11-06-2006 · EurekAlert!
    Researchers at the Yerkes National Primate Research Center, Emory University and the Atlanta VA Hospital have used magnetic resonance imaging to produce images of the eyeХs retinal layers. The research has the potential to revolutionize the way retinal degenerative diseases, such as retinitis pigmentosa, glaucoma, age-related macular degeneration and diabetic retinopathy, are diagnosed and treated. Accelerating detection and treatment of such diseases ultimately could help prevent vision loss.
    Similar news · Read more »
  7. New studies on goats' milk show it is more beneficial to health than cows' milk
    07-30-2007 · EurekAlert!
    It helps to prevent diseases such as anemia and bone demineralization. UGR researchers have carried out a comparative study on the properties of goats' milk compared to those of cows’ milk. Rats with induced nutritional ferropenic anemia have been used in the study. Goats' milk helps digestive and metabolic utilization of minerals such as iron, calcium, phosphorus and magnesium. Part of the results of this research have been published in the prestigious scientific journals International Dairy Journal and Journal Dairy Science.
    Similar news · Read more »
  8. Commonly used pain medications do not prevent Alzheimer's disease
    04-25-2007 · EurekAlert!
    Over-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's disease, according to a study published April 25, 2007, in the online edition of Neurology, the scientific journal of the American Academy of Neurology. These findings appear to contradict earlier observational studies, which found sustained use of nonsteroidal anti-inflammatory drugs may have a protective effect against Alzheimer's disease.
    Similar news · Read more »
  9. Drug treatment slows macular vision loss in diabetics
    12-15-2006 · EurekAlert!
    A drug commonly used to slow the loss of central vision has shown promise in stemming a common precursor of blindness in diabetics, which involves the same central light-sensitive area of retina, Johns Hopkins Wilmer Eye Institute scientists report.
    Similar news · Read more »
  10. Alendronate can help prevent bone fractures in many postmenopausal women
    01-22-2008 · EurekAlert!
    Giving 10mg per day of the bisphosphate drug alendronate to women after their menopause can help prevent loss of bone mass, reducing their risk of fractures, a Cochrane Review has found. This finding applies to women who have started to lose their bone mass but have no fractures (primary prevention), as well as those who have lost significant bone mass and/or have had fractures (secondary prevention).
    Similar news · Read more »